RxDoctor Payments Data

Jadranka Popovic

Pediatric Endocrinology · Pittsburgh, PANPI 1538100193

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $164,829 of the $186,687 with a category attached, or 88.3%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 80.5% of it on its own, with 19 other manufacturers making up the rest. Among pediatric endocrinology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$186,687in general payments, 2019–2025

Across 225 payments — averaging $829.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$150K
  • Tolmar Pharmaceuticals, Inc.$11K
  • Eton Pharmaceuticals, Inc.$8K
  • AbbVie$7K
  • Tolmar, Inc.$7K
  • Novo Nordisk$1K
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$164,82988%
  • Speaking & faculty fees$15,3538%
  • Travel & lodging$4060%
  • Food & beverage$5,5723%
  • Education$5270%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$186,687 in reported general payments places this provider in the 95th percentile of 80 pediatric endocrinology providers in Pennsylvania.

See all pediatric endocrinology providers in Pennsylvania

Other pediatric endocrinology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →